Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-escalation crossover study of fluticasone furoate, fluticasone propionate, and budesonide in asthma
2016-003002-14Phase 2Completed
- Sponsor
- GSK
- Start
- Dec 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of fluticasone, fluticasone propionate and budesonide in asthma (4 arms), sponsored by GSK. Primary endpoint: AMP PC20. Started Dec 2016; status: completed.
02
Drugs
fluticasonefluticasone propionatebudesonide
03
Conditions
asthma
Beyond the preview
Go deeper on 2016-003002-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003002-14.